Numerous pathological stimuli lead to cardiac hypertrophy. The winding roads to pathological cardiac growth now seem to converge on one protein, histone deacetylase (HDAC).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Reprinted with permission from Elsevier Science
References
Chien, K.R. Stress pathways and heart failure. Cell 98, 555–558 (1999).
Zhang, C.L. et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479–488 (2002).
Jenuwein, T. & Allis, C.D. Translating the histone code. Science 293, 1074–1080 (2001).
Frey, N., McKinsey, T.A. & Olson, E.N. Decoding calcium signals involved in cardiac growth and function. Nature Med. 6, 1221–1227 (2000).
McKinsey, T.A., Zhang, C.L. & Olson, E.N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3- 3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 97, 14400–14405 (2000).
McKinsey, T.A., Zhang, C.L. & Olson, E.N. MEF2: A calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27, 40–47 (2002).
Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215–228 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Metzger, J. HDAC lightens a heavy heart. Nat Med 8, 1078–1079 (2002). https://doi.org/10.1038/nm1002-1078
Issue Date:
DOI: https://doi.org/10.1038/nm1002-1078
This article is cited by
-
Histone deacetylase inhibitors—turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases
Applied Microbiology and Biotechnology (2007)
